ZALIFRELIMAB

AGEN-1884 AGEN1884 A HUMAN MONOCLONAL ANTIBODY TARGETING CYTOTOXIC T LYMPHOCYTE ASSOCIATED PROTEIN 4 (CTLA4) ANTI-CTLA-4 MONOCLONAL ANTIBODY AGEN1884 IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL AGEN1884 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN1884 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC TLYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CYTOTOXIC T-LYMPHOCYTE PROTEIN 4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4CTLA-4CD152 ANTIGEN))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-448) (HOMO SAPIENS VH (IGHV3-21*01 (IGHD)-IGHJ3*02) (8.8.11) (1-118)-HOMO SAPIENS IGHG1*03 (119-448)) (221-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-20*01 (95%) IGKJ1*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE UGN-301 zalifrelimab [INN] ZALIFRELIMAB [USAN] Zalifrelimab [WHO-DD]